| Curtis Optometry Group, Pllc | |
| 1823 5th St N, Columbus, Mississippi 39705 | |
| (662) 328-5225 |
| Name | Curtis Optometry Group, Pllc |
|---|---|
| Organization Name | Curtis Optometry Group Pllc |
| Location | 1823 5th St N, Columbus, Mississippi 39705 |
| Type | Supplier |
| Phone | (662) 328-5225 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Rhode Island Hospital has received a grant for more than $1.5 million from the National Institute of Mental Health (NIMH) for a 5-year study on treatment for Body Dysmorphic Disorder (BDD). Led by Katharine A. Phillips, M.D., director of the BDD Program at Rhode Island Hospital and an internationally known expert in BDD, the study will examine the effectiveness of cognitive behavioral therapy versus supportive psychotherapy for the treatment of people with BDD.
Thousands of consumer products containing engineered nanoparticles — microscopic particles found in everyday items from cosmetics and clothing to building materials — enter the market every year. Concerns about possible environmental health and safety issues of these nano-enabled products continue to grow with scientists struggling to come up with fast, cheap, and easy-to-use cellular screening systems to determine possible hazards of vast libraries of engineered nanomaterials.
Bronner is one of six people from the St. Louis area whom NPR has been following for a little more than a year. Like the others, she started 2011 unemployed and searching for work. Like so many Americans who have struggled in this tough labor market, the people we followed have had difficulty getting health coverage. And for some, including Bronner, it didn't stop when they got jobs.
The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."
Exelixis, Inc. today announced results from two analyses evaluating the effect of PD-L1 expression or prior treatment with immune checkpoint inhibitors on the efficacy of cabozantinib in patients with advanced renal cell carcinoma (RCC). The findings are being presented this week at the European Society for Medical Oncology 2018 Congress being held October 19-23 in Munich, Germany.
› Verified 8 days ago
News Archive
Rhode Island Hospital has received a grant for more than $1.5 million from the National Institute of Mental Health (NIMH) for a 5-year study on treatment for Body Dysmorphic Disorder (BDD). Led by Katharine A. Phillips, M.D., director of the BDD Program at Rhode Island Hospital and an internationally known expert in BDD, the study will examine the effectiveness of cognitive behavioral therapy versus supportive psychotherapy for the treatment of people with BDD.
Thousands of consumer products containing engineered nanoparticles — microscopic particles found in everyday items from cosmetics and clothing to building materials — enter the market every year. Concerns about possible environmental health and safety issues of these nano-enabled products continue to grow with scientists struggling to come up with fast, cheap, and easy-to-use cellular screening systems to determine possible hazards of vast libraries of engineered nanomaterials.
Bronner is one of six people from the St. Louis area whom NPR has been following for a little more than a year. Like the others, she started 2011 unemployed and searching for work. Like so many Americans who have struggled in this tough labor market, the people we followed have had difficulty getting health coverage. And for some, including Bronner, it didn't stop when they got jobs.
The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."
Exelixis, Inc. today announced results from two analyses evaluating the effect of PD-L1 expression or prior treatment with immune checkpoint inhibitors on the efficacy of cabozantinib in patients with advanced renal cell carcinoma (RCC). The findings are being presented this week at the European Society for Medical Oncology 2018 Congress being held October 19-23 in Munich, Germany.
› Verified 8 days ago
Tolley Valerie/health C Type: DME Supplier - Oxygen Equipment & Supplies Location: 818 2nd Ave N, Columbus, Mississippi 39701 Phone: (662) 329-5001 | |
Walgreens #2676 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1728 Highway 45 N, Columbus, Mississippi 39705 Phone: (662) 328-0747 | |
Kroger Pharmacy 427 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1829 Highway 45 N, Columbus, Mississippi 39705 Phone: (601) 327-9562 | |
Wal-mart Pharmacy 10-0495 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1913 Highway 45 N, Columbus, Mississippi 39705 Phone: (662) 329-1766 | |
Southern Drugs Type: Pharmacy Location: 1202 Main St, Columbus, Mississippi 39701 Phone: (662) 328-0833 |